Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry M Feher, JM Schmidt Journal of chemical information and computer sciences 43 (1), 218-227, 2003 | 1283 | 2003 |
Consensus scoring for protein–ligand interactions M Feher Drug discovery today 11 (9-10), 421-428, 2006 | 304 | 2006 |
Flexible alignment of small molecules P Labute, C Williams, M Feher, E Sourial, JM Schmidt Journal of medicinal chemistry 44 (10), 1483-1490, 2001 | 220 | 2001 |
A simple model for the prediction of blood–brain partitioning M Feher, E Sourial, JM Schmidt International journal of pharmaceutics 201 (2), 239-247, 2000 | 149 | 2000 |
The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5 … PB Sampson, Y Liu, B Forrest, G Cumming, SW Li, NK Patel, L Edwards, ... Journal of medicinal chemistry 58 (1), 147-169, 2015 | 137 | 2015 |
The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones as Orally Bioavailable Antitumor … PB Sampson, Y Liu, NK Patel, M Feher, B Forrest, SW Li, L Edwards, ... Journal of Medicinal Chemistry 58 (1), 130-146, 2015 | 121 | 2015 |
Electronic and photoelectron spectroscopy: fundamentals and case studies AM Ellis, M Fehér, TG Wright Cambridge University Press, 2005 | 105 | 2005 |
The use of consensus scoring in ligand-based virtual screening JC Baber, WA Shirley, Y Gao, M Feher Journal of chemical information and modeling 46 (1), 277-288, 2006 | 103 | 2006 |
Tunable diode laser monitoring of atmospheric trace gas constituents M Feher, PA Martin Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 51 (10 …, 1995 | 99 | 1995 |
Optoacoustic trace-gas monitoring with near-infrared diode lasers M Fehér, Y Jiang, JP Maier, A Miklós Applied optics 33 (9), 1655-1658, 1994 | 96 | 1994 |
Structural chemistry of the histone methyltransferases cofactor binding site V Campagna-Slater, MW Mok, KT Nguyen, M Feher, R Najmanovich, ... Journal of chemical information and modeling 51 (3), 612-623, 2011 | 88 | 2011 |
Novel 2D fingerprints for ligand-based virtual screening T Ewing, JC Baber, M Feher Journal of chemical information and modeling 46 (6), 2423-2431, 2006 | 86 | 2006 |
Synthesis and evaluation of a novel nonsteroidal-specific endothelial cell proliferation inhibitor JM Schmidt, GB Tremblay, M Pagé, J Mercure, M Feher, R Dunn-Dufault, ... Journal of medicinal chemistry 46 (8), 1289-1292, 2003 | 85 | 2003 |
Effect of input differences on the results of docking calculations M Feher, CI Williams Journal of chemical information and modeling 49 (7), 1704-1714, 2009 | 75 | 2009 |
Fragment hits: What do they look like and how do they bind? F Giordanetto, C Jin, L Willmore, M Feher, DE Shaw Journal of medicinal chemistry 62 (7), 3381-3394, 2019 | 74 | 2019 |
The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents R Laufer, B Forrest, SW Li, Y Liu, P Sampson, L Edwards, Y Lang, ... Journal of medicinal chemistry 56 (15), 6069-6087, 2013 | 72 | 2013 |
Predicting synthetic accessibility: application in drug discovery and development. JC Baber, M Feher Mini reviews in medicinal chemistry 4 (6), 681-692, 2004 | 72 | 2004 |
Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer Agent Y Liu, R Laufer, NK Patel, G Ng, PB Sampson, SW Li, Y Lang, M Feher, ... ACS Medicinal Chemistry Letters 7 (7), 671-675, 2016 | 66 | 2016 |
Quantum chemistry: fundamentals to applications T Veszprémi, M Fehér Springer Science & Business Media, 2012 | 64 | 2012 |
The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents Y Liu, Y Lang, NK Patel, G Ng, R Laufer, SW Li, L Edwards, B Forrest, ... Journal of medicinal chemistry 58 (8), 3366-3392, 2015 | 63 | 2015 |